TGTX in the 13F filings
TG Therapeutics Inc · CUSIP 88322Q108
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 30
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 6 listed it in both
- Shares listed
- 12,353,558
- combined, among listed positions
- Reported value
- $368m
- combined, at the quarter end
Among the 92 comparable managers: 23 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,594,297.
Managers listing TGTX in Q4 2025
30 of 30 holders
Largest increases and reductions, by shares
Increases
- Invesco Ltdexisting position · 1,609,815 shares now+515,481
- D. E. Shaw & Co.existing position · 700,345 shares now+468,322
- Millennium Management LLCexisting position · 675,910 shares now+385,023
- Squarepoint Ops LLCexisting position · 852,522 shares now+347,888
- Voloridge Investment Management LLCexisting position · 560,727 shares now+347,821
Reductions
- Fidelity (FMR LLC)existing position · 226,996 shares now-484,347
- T. Rowe Price Associates Incexisting position · 605,945 shares now-352,526
- Jane Street Group LLCexisting position · 969,975 shares now-158,785
- Point72 Asset Management LPexisting position · 231,358 shares now-134,474
- Winton Group Ltdexisting position · 25,242 shares now-99,758
New positions and exits
New (4)
Exited (2)
- Balyasny Asset Management LLCwas $6.6m
- Verition Fund Management LLCwas $1.7m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2018 | 2 | $9.0m | n.a. | n.a. |
| Q1 2019 | 2 | $50m | n.a. | n.a. |
| Q2 2019 | 2 | $52m | n.a. | n.a. |
| Q3 2019 | 1 | $42m | n.a. | n.a. |
| Q1 2020 | 1 | $162k | n.a. | n.a. |
| Q2 2020 | 4 | $47m | n.a. | n.a. |
| Q3 2020 | 3 | $416m | n.a. | n.a. |
| Q4 2020 | 7 | $1.3bn | n.a. | n.a. |
| Q1 2021 | 6 | $1.4bn | n.a. | n.a. |
| Q2 2021 | 6 | $1.2bn | n.a. | n.a. |
| Q3 2021 | 4 | $893m | n.a. | n.a. |
| Q4 2021 | 2 | $194m | n.a. | n.a. |
| Q1 2022 | 2 | $74m | n.a. | n.a. |
| Q2 2022 | 2 | $29m | n.a. | n.a. |
| Q3 2022 | 2 | $51m | n.a. | n.a. |
| Q4 2022 | 5 | $108m | n.a. | n.a. |
| Q1 2023 | 3 | $55m | n.a. | n.a. |
| Q2 2023 | 7 | $154m | n.a. | n.a. |
| Q3 2023 | 5 | $47m | n.a. | n.a. |
| Q4 2023 | 2 | $36m | 1 | 2 |
| Q1 2024 | 3 | $37m | 2 | 1 |
| Q2 2024 | 6 | $109m | 6 | 0 |
| Q3 2024 | 6 | $94m | 4 | 3 |
| Q4 2024 | 3 | $2.7m | 0 | 3 |
| Q1 2025 | 5 | $57m | 3 | 1 |
| Q2 2025 | 4 | $49m | 3 | 1 |
| Q3 2025 | 6 | $102m | 5 | 1 |
| Q4 2025 | 6 | $83m | 23 | 8 |
| Q1 2026 | 5 | $88m | 14 | 17 |
| Q2 2026 | 8 | $445m | 21 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TGTX and LLY →TGTX and JNJ →TGTX and VRTX →Choose a stock to compare with TGTX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TGTX, latest filings →Back to the 13F Explorer →